Dib M - Search Results

1

Riluzole rescues cochlear sensory cells from acoustic trauma in the guinea-pig.

Wang J, Dib M, Lenoir M, Vago P, Eybalin M, Hameg A, Pujol R, Puel JL. Wang J, et al. Among authors: dib m. Neuroscience. 2002;111(3):635-48. doi: 10.1016/s0306-4522(02)00004-0. Neuroscience. 2002. PMID: 12031350

2

Neuroprotective effect of riluzole in acute noise-induced hearing loss.

Ruel J, Wang J, Pujol R, Hameg A, Dib M, Puel JL. Ruel J, et al. Among authors: dib m. Neuroreport. 2005 Jul 13;16(10):1087-90. doi: 10.1097/00001756-200507130-00011. Neuroreport. 2005. PMID: 15973153

3

5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle.

Alvarez-Guerra M, Hameg A, Bayle F, Dib M, Garay RP. Alvarez-Guerra M, et al. Among authors: dib m. Eur J Pharmacol. 2002 Nov 15;454(2-3):235-9. doi: 10.1016/s0014-2999(02)02489-5. Eur J Pharmacol. 2002. PMID: 12421652

4

Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes.

Hameg A, Bayle F, Nuss P, Dupuis P, Garay RP, Dib M. Hameg A, et al. Among authors: dib m. Biochem Pharmacol. 2003 Feb 1;65(3):435-40. doi: 10.1016/s0006-2952(02)01515-0. Biochem Pharmacol. 2003. PMID: 12527336

5

Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine.

Peinado J, Hameg A, Garay RP, Bayle F, Nuss P, Dib M. Peinado J, et al. Among authors: dib m. Naunyn Schmiedebergs Arch Pharmacol. 2003 Feb;367(2):134-9. doi: 10.1007/s00210-002-0665-4. Epub 2003 Jan 23. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12595954

6

A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian).

Hodé Y, Reimold M, Demazières A, Reischl G, Bayle F, Nuss P, Hameg A, Dib M, Macher JP. Hodé Y, et al. Among authors: dib m. Psychopharmacology (Berl). 2005 Jul;180(2):377-84. doi: 10.1007/s00213-005-2172-z. Epub 2005 Mar 15. Psychopharmacology (Berl). 2005. PMID: 15948013

7

5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity.

Alvarez-Guerra M, d'Alché-Birée F, Wolf WA, Vargas F, Dib M, Garay RP. Alvarez-Guerra M, et al. Among authors: dib m. Psychopharmacology (Berl). 2000 Jan;147(4):412-7. doi: 10.1007/s002130050010. Psychopharmacology (Berl). 2000. PMID: 10672635

8

Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.

Lemoine P, Kermadi I, Garcia-Acosta S, Garay RP, Dib M. Lemoine P, et al. Among authors: dib m. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):131-7. doi: 10.1016/j.pnpbp.2005.08.015. Epub 2005 Oct 21. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16243418 Clinical Trial.

9

Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice.

Bourin M, Nic Dhonnchadha BA, Claude Colombel M, Dib M, Hascoët M. Bourin M, et al. Among authors: dib m. Behav Brain Res. 2001 Sep 28;124(1):87-95. doi: 10.1016/s0166-4328(01)00238-8. Behav Brain Res. 2001. PMID: 11423169

10

Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome.

Favre JD, Allain H, Aubin HJ, Frija-Orvoen E, Gillet C, Lejoyeux M, Payen A, Weber M, Garcia-Acosta S, Kermadi I, Dib M. Favre JD, et al. Among authors: dib m. Hum Psychopharmacol. 2005 Oct;20(7):511-9. doi: 10.1002/hup.718. Hum Psychopharmacol. 2005. PMID: 16118830 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters